Postes actifs de David S. Johnson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
GigaGen, Inc.
 GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | - | - |
| Directeur Général | 01/01/2010 | - | |
| Fondateur | 01/01/2010 | - | |
| President | 01/01/2010 | - | |
GigaMune, Inc.
 GigaMune, Inc. BiotechnologyHealth Technology GigaMune, Inc. is an American cancer cell therapy company that is focused on advancing T cell therapies for cancer. GigaMune was founded in 2017 as a spin-out from Gigagen and is located in an undisclosed location. The company captures and engineer T cell receptors (TCRs) directed against solid tumor targets using their industry-leading technology for TCR repertoire capture. The CEO of the company is David S. Johnson. | Directeur Général | - | - |
| Directeur Financier/CFO | - | - | |
| Secrétaire Général | - | - |
Historique de carrière de David S. Johnson
Anciens postes connus de David S. Johnson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NATERA, INC. | Directeur des opérations | - | - |
| Stanford University | Corporate Officer/Principal | - | - |
Formation de David S. Johnson
| Stanford University | Doctorate Degree |
| Duke University | Undergraduate Degree |
| Haas School of Business | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NATERA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
GigaGen, Inc.
GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | Health Technology |
GigaMune, Inc.
GigaMune, Inc. BiotechnologyHealth Technology GigaMune, Inc. is an American cancer cell therapy company that is focused on advancing T cell therapies for cancer. GigaMune was founded in 2017 as a spin-out from Gigagen and is located in an undisclosed location. The company captures and engineer T cell receptors (TCRs) directed against solid tumor targets using their industry-leading technology for TCR repertoire capture. The CEO of the company is David S. Johnson. | Health Technology |
- Bourse
- Insiders
- David S. Johnson
- Expérience
